
Cancer Gene Therapy Global Market Report 2025
Description
Cancer Gene Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cancer gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for cancer gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cancer gene therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Therapy: Gene Induced Immunotherapy; Oncolytic Virotherapy; Gene Transfer
2) By Indication: Large B-Cell Lymphoma; Multiple Myeloma; Acute Lymphoblastic Leukemia (ALL); Melanoma (lesions); Other Indications
3) By Vector Type: Lentivirus; RetroVirus And Gamma RetroVirus; Adeno-Associated Virus (AAV); Modified Herpes Simplex Virus; Adenovirus; Other Vector Types
4) By End-User: Hospitals; Research Institutes; Biopharma Companies; Diagnostic centers; Other End Users
Subsegments:
1) By Gene Induced Immunotherapy: CAR-T Cell Therapy; TCR (T-Cell Receptor) Therapy; Tumor-Infiltrating Lymphocyte (TIL) Therapy; Dendritic Cell-Based Gene Therapy; NK Cell Gene Therapy
2) By Oncolytic Virotherapy: Adenoviruses; Herpes Simplex Virus (HSV); Reovirus; Vaccinia Virus; Newcastle Disease Virus (NDV)
3) By Gene Transfer: Viral Gene Transfer; Non-Viral Gene Transfer
Companies Mentioned: Bristol Myers Company; Novartis AG; GSK plc.; Gilead Sciences Inc.; Amgen Inc.; Orchard Therapeutics Plc; Biogen Inc.; Sarepta Therapeutics Inc.; AGC Biologics; Adaptimmune Limited; Sibiono; Elevate Bio Inc.; Bluebird Bio Inc.; Uniqure N.V.; Shanghai Sunway Biotech Co. Ltd.; Anges Inc.; Gensight Biologics; Genelux Corporation; Cellectis; Abeona Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on cancer gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cancer gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cancer gene therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Therapy: Gene Induced Immunotherapy; Oncolytic Virotherapy; Gene Transfer
2) By Indication: Large B-Cell Lymphoma; Multiple Myeloma; Acute Lymphoblastic Leukemia (ALL); Melanoma (lesions); Other Indications
3) By Vector Type: Lentivirus; RetroVirus And Gamma RetroVirus; Adeno-Associated Virus (AAV); Modified Herpes Simplex Virus; Adenovirus; Other Vector Types
4) By End-User: Hospitals; Research Institutes; Biopharma Companies; Diagnostic centers; Other End Users
Subsegments:
1) By Gene Induced Immunotherapy: CAR-T Cell Therapy; TCR (T-Cell Receptor) Therapy; Tumor-Infiltrating Lymphocyte (TIL) Therapy; Dendritic Cell-Based Gene Therapy; NK Cell Gene Therapy
2) By Oncolytic Virotherapy: Adenoviruses; Herpes Simplex Virus (HSV); Reovirus; Vaccinia Virus; Newcastle Disease Virus (NDV)
3) By Gene Transfer: Viral Gene Transfer; Non-Viral Gene Transfer
Companies Mentioned: Bristol Myers Company; Novartis AG; GSK plc.; Gilead Sciences Inc.; Amgen Inc.; Orchard Therapeutics Plc; Biogen Inc.; Sarepta Therapeutics Inc.; AGC Biologics; Adaptimmune Limited; Sibiono; Elevate Bio Inc.; Bluebird Bio Inc.; Uniqure N.V.; Shanghai Sunway Biotech Co. Ltd.; Anges Inc.; Gensight Biologics; Genelux Corporation; Cellectis; Abeona Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Cancer Gene Therapy Market Characteristics
- 3. Cancer Gene Therapy Market Trends And Strategies
- 4. Cancer Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Cancer Gene Therapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cancer Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cancer Gene Therapy Market Growth Rate Analysis
- 5.4. Global Cancer Gene Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cancer Gene Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cancer Gene Therapy Total Addressable Market (TAM)
- 6. Cancer Gene Therapy Market Segmentation
- 6.1. Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gene Induced Immunotherapy
- Oncolytic Virotherapy
- Gene Transfer
- 6.2. Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Large B-Cell Lymphoma
- Multiple Myeloma
- Acute Lymphoblastic Leukemia (ALL)
- Melanoma
- Other Indications
- 6.3. Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lentivirus
- RetroVirus And Gamma RetroVirus
- Adeno-Associated Virus (AAV)
- Modified Herpes Simplex Virus
- Adenovirus
- Other Vector Types
- 6.4. Global Cancer Gene Therapy Market, Segmentation By End-User , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Research Institutes
- Biopharma Companies
- Diagnostic Centers
- Other End Users
- 6.5. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CAR-T Cell Therapy
- TCR (T-Cell Receptor) Therapy
- Tumor-Infiltrating Lymphocyte (TIL) Therapy
- Dendritic Cell-Based Gene Therapy
- NK Cell Gene Therapy
- 6.6. Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Adenoviruses
- Herpes Simplex Virus (HSV)
- Reovirus
- Vaccinia Virus
- Newcastle Disease Virus (NDV)
- 6.7. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Viral Gene Transfer
- Non-Viral Gene Transfer
- 7. Cancer Gene Therapy Market Regional And Country Analysis
- 7.1. Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Cancer Gene Therapy Market
- 8.1. Asia-Pacific Cancer Gene Therapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Cancer Gene Therapy Market
- 9.1. China Cancer Gene Therapy Market Overview
- 9.2. China Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Cancer Gene Therapy Market
- 10.1. India Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Cancer Gene Therapy Market
- 11.1. Japan Cancer Gene Therapy Market Overview
- 11.2. Japan Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Cancer Gene Therapy Market
- 12.1. Australia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Cancer Gene Therapy Market
- 13.1. Indonesia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Cancer Gene Therapy Market
- 14.1. South Korea Cancer Gene Therapy Market Overview
- 14.2. South Korea Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Cancer Gene Therapy Market
- 15.1. Western Europe Cancer Gene Therapy Market Overview
- 15.2. Western Europe Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Cancer Gene Therapy Market
- 16.1. UK Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Cancer Gene Therapy Market
- 17.1. Germany Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Cancer Gene Therapy Market
- 18.1. France Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Cancer Gene Therapy Market
- 19.1. Italy Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Cancer Gene Therapy Market
- 20.1. Spain Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Cancer Gene Therapy Market
- 21.1. Eastern Europe Cancer Gene Therapy Market Overview
- 21.2. Eastern Europe Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Cancer Gene Therapy Market
- 22.1. Russia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Cancer Gene Therapy Market
- 23.1. North America Cancer Gene Therapy Market Overview
- 23.2. North America Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Cancer Gene Therapy Market
- 24.1. USA Cancer Gene Therapy Market Overview
- 24.2. USA Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Cancer Gene Therapy Market
- 25.1. Canada Cancer Gene Therapy Market Overview
- 25.2. Canada Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Cancer Gene Therapy Market
- 26.1. South America Cancer Gene Therapy Market Overview
- 26.2. South America Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Cancer Gene Therapy Market
- 27.1. Brazil Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Cancer Gene Therapy Market
- 28.1. Middle East Cancer Gene Therapy Market Overview
- 28.2. Middle East Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Cancer Gene Therapy Market
- 29.1. Africa Cancer Gene Therapy Market Overview
- 29.2. Africa Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Cancer Gene Therapy Market Competitive Landscape And Company Profiles
- 30.1. Cancer Gene Therapy Market Competitive Landscape
- 30.2. Cancer Gene Therapy Market Company Profiles
- 30.2.1. Bristol Myers Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GSK plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Cancer Gene Therapy Market Other Major And Innovative Companies
- 31.1. Orchard Therapeutics Plc
- 31.2. Biogen Inc.
- 31.3. Sarepta Therapeutics Inc.
- 31.4. AGC Biologics
- 31.5. Adaptimmune Limited
- 31.6. Sibiono
- 31.7. Elevate Bio Inc.
- 31.8. Bluebird Bio Inc.
- 31.9. Uniqure N.V.
- 31.10. Shanghai Sunway Biotech Co. Ltd.
- 31.11. Anges Inc.
- 31.12. Gensight Biologics
- 31.13. Genelux Corporation
- 31.14. Cellectis
- 31.15. Abeona Therapeutics Inc.
- 32. Global Cancer Gene Therapy Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Cancer Gene Therapy Market
- 34. Recent Developments In The Cancer Gene Therapy Market
- 35. Cancer Gene Therapy Market High Potential Countries, Segments and Strategies
- 35.1 Cancer Gene Therapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cancer Gene Therapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cancer Gene Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.